Catalio Capital Management, LP
Annual return '25
+39.9%
SPY '25
+17.7%
Alpha
+22.2ptsvs SPY
Invested
$478.7M
Holdings
41
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 97%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$DNTH
DIANTHUS THERAPEUTICS INC
Held since at least Q1 2024
9.8%
02
$BBIO
BRIDGEBIO PHARMA INC
Held since at least Q1 2024
6.7%
03
$ASND
ASCENDIS PHARMA A/S
Held since at least Q1 2024
6.2%
04
$BMY
BRISTOL-MYERS SQUIBB CO
Q1 2026: Sold 1.6% (15.1k → 14.9k shares)
5.3%
05
$SNDX
SYNDAX PHARMACEUTICALS INC
Held since at least Q1 2024
5.1%
06
$GILD
GILEAD SCIENCES INC
Q1 2026: Exited (was 77 shares)
4.8%
07
$TERN
TERNS PHARMACEUTICALS INC
Held since at least Q1 2024
4.5%
08
$DFTX
DEFINIUM THERAPEUTICS INC
Held since at least Q1 2024
4.1%
09
$SLNO
SOLENO THERAPEUTICS INC
Held since at least Q1 2024
4.0%
10
$BSX
BOSTON SCIENTIFIC CORP
Q1 2026: Increased +24281.8% (22 → 5.4k shares)
3.9%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 10:01 UTC.